Dr. Welsh on New Understanding of Regulating PD-L1 Expression

James Welsh, MD
Published: Tuesday, Apr 21, 2015



James Welsh, MD, associate professor of Radiation Oncology, The University of Texas MD Anderson Cancer Center, discusses a study that examined the regulation of PD-L1 and how it may open up more treatment options for patients with non-small cell lung cancer.

The study discovered information regarding how the PD-L1 pathway is regulated by the tumor suppressor gene p53, Welsh explains. However, researchers have had trouble understanding how to target the mutation. The study showed that p53 regulates PD-L1 expression through miR-34a.

Understanding more of the mechanisms behind the pathway may open up new therapy options for patients, he adds. Welsh expects additional solid tumors to be treated with PD-1 or PD-L1 agents in the near future.

<<< View more from the 2015 AACR Annual Meeting



James Welsh, MD, associate professor of Radiation Oncology, The University of Texas MD Anderson Cancer Center, discusses a study that examined the regulation of PD-L1 and how it may open up more treatment options for patients with non-small cell lung cancer.

The study discovered information regarding how the PD-L1 pathway is regulated by the tumor suppressor gene p53, Welsh explains. However, researchers have had trouble understanding how to target the mutation. The study showed that p53 regulates PD-L1 expression through miR-34a.

Understanding more of the mechanisms behind the pathway may open up new therapy options for patients, he adds. Welsh expects additional solid tumors to be treated with PD-1 or PD-L1 agents in the near future.

<<< View more from the 2015 AACR Annual Meeting




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine TumorsMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x